{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:16:37Z","timestamp":1770941797638,"version":"3.50.1"},"reference-count":89,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Postgraduate Medicine"],"published-print":{"date-parts":[[2015,1,2]]},"DOI":"10.1080\/00325481.2015.998593","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T15:31:27Z","timestamp":1455723087000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspective"],"prefix":"10.1080","volume":"127","author":[{"given":"Casilda M.","family":"Balmaceda","sequence":"first","affiliation":[{"name":"Department of Neurology, Columbia University Medical Center","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,1,13]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23176"},{"key":"e_1_3_3_3_1","first-page":"677","article-title":"Prevalence and burden of osteoarthritis: results from a population survey in Norway","volume":"35","author":"Grotle M","year":"2008","unstructured":"Grotle M, Hagen KB, Natvig B, Dahl F, Kvien TK. Prevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol 2008;35:677\u201384.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324607"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24984"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3181cf00aa"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3181715111"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-38"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-72"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.181424"},{"key":"e_1_3_3_11_1","first-page":"2218","article-title":"Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs","volume":"32","author":"Wilcox CM","year":"2005","unstructured":"Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005;32:2218\u201324.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050493"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.861104"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.616219"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050405"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.004671"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.3810\/psm.2011.09.1922"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903311023"},{"key":"e_1_3_3_20_1","first-page":"551","article-title":"Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure","volume":"88","author":"Evans JM","year":"1995","unstructured":"Evans JM, McGregor E, McMahon AD, et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995;88:551\u20137.","journal-title":"QJM"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/11539430-000000000-00000"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.02.005"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.10.005"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02376.x"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31821daaf6"},{"key":"e_1_3_3_26_1","first-page":"1126","article-title":"Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease","volume":"98","author":"Johnson J","year":"2006","unstructured":"Johnson J, Weinryb J. Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease. J Natl Med Assoc 2006;98:1126\u201335.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_3_27_1","first-page":"A73","article-title":"Awareness of racial and socioeconomic health disparities in the United States: the national opinion survey on health and health disparities, 2008-2009","volume":"8","author":"Booske BC","year":"2011","unstructured":"Booske BC, Robert SA, Rohan AM. Awareness of racial and socioeconomic health disparities in the United States: the national opinion survey on health and health disparities, 2008-2009. Prev Chronic Dis 2011;8:A73.","journal-title":"Prev Chronic Dis"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.166082"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029202"},{"key":"e_1_3_3_30_1","first-page":"1","article-title":"CDC health disparities and inequalities report \u2013 United States, 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. CDC health disparities and inequalities report \u2013 United States, 2011. MMWR Morb Mortal Wkly Rep 2011;60(Suppl):1\u2013113.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31823ac046"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012848"},{"key":"e_1_3_3_33_1","first-page":"429","article-title":"Racial\/ethnic disparities on self-reported hypertension in New York City: examining disparities among Hispanic subgroups","volume":"21","author":"Borrell LN","year":"2011","unstructured":"Borrell LN, Menendez BS, Joseph SP. Racial\/ethnic disparities on self-reported hypertension in New York City: examining disparities among Hispanic subgroups. Ethn Dis 2011;21:429\u201336.","journal-title":"Ethn Dis"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2494"},{"key":"e_1_3_3_35_1","first-page":"177","article-title":"Hypertension related mortality among Hispanic populations-United States 1995-2002","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","unstructured":"Centers for Disease Control and Prevention. Hypertension related mortality among Hispanic populations-United States 1995-2002. MMWR Morb Mortal Wkly Rep 2006;55:177\u201380.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2011.300452"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0062"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0412"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-0407.2010.00078.x"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.120055"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-009-0023-8"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2010.05.006"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.7.1769"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2006.09.019"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705623"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.2.382"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.044149"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1139\/y01-065"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.05.028"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S27275"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21596"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011742"},{"key":"e_1_3_3_53_1","first-page":"CD004257","article-title":"Acetaminophen for osteoarthritis","author":"Towheed TE","year":"2006","unstructured":"Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006:CD004257.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_54_1","unstructured":"FDA drug safety communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. Available from http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm239821.htm. Accessed 21 March 2014."},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01388.x"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20948"},{"key":"e_1_3_3_57_1","volume-title":"Norco\u2122 (hydrocodone bitartrate and acetaminophen tablets). Full Prescribing Information [package insert]","year":"2014","unstructured":"Norco\u2122 (hydrocodone bitartrate and acetaminophen tablets). Full Prescribing Information [package insert]. Parsippany, NJ: Actavis Pharma, Inc; 2014."},{"key":"e_1_3_3_58_1","volume-title":"Xartemis\u2122 XR (oxycodone hydrochloride and acetaminophen extended-release tablets). Full Prescribing Information [package insert]","year":"2014","unstructured":"Xartemis\u2122 XR (oxycodone hydrochloride and acetaminophen extended-release tablets). Full Prescribing Information [package insert]. Hazelwood, MO: Mallinckrodt Brand Pharmaceuticals, Inc; 2014."},{"key":"e_1_3_3_59_1","first-page":"CD003328","article-title":"Interventions for paracetamol (acetaminophen) overdose","author":"Brok J","year":"2006","unstructured":"Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2006:CD003328.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.696097"},{"key":"e_1_3_3_61_1","volume-title":"Ultram\u00ae (tramadol hydrochloride tablets). Full Prescribing Information [package insert]","year":"2004","unstructured":"Ultram\u00ae (tramadol hydrochloride tablets). Full Prescribing Information [package insert]. Raritan, NJ: Ortho-McNeil; 2004."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr017"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1129"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08l00690"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aem325"},{"key":"e_1_3_3_66_1","volume-title":"Ultram\u00ae ER (tramadol hydrochloride). Full Prescribing Information [package insert]","year":"2009","unstructured":"Ultram\u00ae ER (tramadol hydrochloride). Full Prescribing Information [package insert]. Raritan, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2009."},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1159\/000326085"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.11.002"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.1.75"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.125783"},{"key":"e_1_3_3_72_1","first-page":"383","article-title":"Treatment of arthritis with topical capsaicin: a double-blind trial","volume":"13","author":"Deal CL","year":"1991","unstructured":"Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991;13:383\u201395.","journal-title":"Clin Ther"},{"key":"e_1_3_3_73_1","first-page":"604","article-title":"Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands","volume":"19","author":"McCarthy GM","year":"1992","unstructured":"McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992;19:604\u20137.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_74_1","volume-title":"Qutenza\u00ae (capsaicin 8% patch). Full Prescribing Information [package insert]","year":"2009","unstructured":"Qutenza\u00ae (capsaicin 8% patch). Full Prescribing Information [package insert]. Ardsley, NY: Acorda Therapeutics, Inc; 2009."},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-221"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10777"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200909000-00006"},{"key":"e_1_3_3_78_1","volume-title":"Voltaren\u00ae Gel 1% (diclofenac sodium topical gel). Full Prescribing Information [package insert]","year":"2009","unstructured":"Voltaren\u00ae Gel 1% (diclofenac sodium topical gel). Full Prescribing Information [package insert]. Parsippany, NJ: Novartis Consumer Health, Inc; 2009."},{"key":"e_1_3_3_79_1","volume-title":"PENNSAID\u00ae (diclofenac sodium topical solution). Full Prescribing Information [package insert]","year":"2010","unstructured":"PENNSAID\u00ae (diclofenac sodium topical solution). Full Prescribing Information [package insert]. Varennes, QC, Canada: Nuvo Manufacturing; 2010."},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081316"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2009.09.002"},{"key":"e_1_3_3_82_1","first-page":"2384","article-title":"Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee","volume":"32","author":"Niethard FU","year":"2005","unstructured":"Niethard FU, Gold MS, Solomon GS, et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 2005;32:2384\u201392.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.03.008"},{"key":"e_1_3_3_84_1","first-page":"567","article-title":"Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials","volume":"33","author":"Towheed TE","year":"2006","unstructured":"Towheed TE. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 2006;33:567\u201373.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_85_1","first-page":"2002","article-title":"Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial","volume":"31","author":"Tugwell PS","year":"2004","unstructured":"Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004;31:2002\u201312.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009336234"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2507"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2011.12.002"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.11.012"},{"key":"e_1_3_3_90_1","volume-title":"Osteoarthritis: national clinical guideline for care and management in adults","author":"National Collaborating Centre for Chronic Conditions","year":"2008","unstructured":"National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. London, UK: Royal College of Physicians; 2008."}],"container-title":["Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00325481.2015.998593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:38:27Z","timestamp":1770939507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00325481.2015.998593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,2]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,2]]}},"alternative-id":["10.1080\/00325481.2015.998593"],"URL":"https:\/\/doi.org\/10.1080\/00325481.2015.998593","relation":{},"ISSN":["0032-5481","1941-9260"],"issn-type":[{"value":"0032-5481","type":"print"},{"value":"1941-9260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}